Veterinary Medicines

Kenocidin Spray and Dip Chloorhexidine Digluconaat 5 mg/ml Teat dip/spray solution

Authorised
  • Chlorhexidine gluconate
Download as PDF

Product identification

Medicine name:
Kenocidin Spray and Dip Chloorhexidine digluconaat 5mg/ml, tepeldip oplossing / tepelspray oplossing voor runderen (melkkoeien)
Kenocidin Spray and Dip Chloorhexidine Digluconaat 5 mg/ml Teat dip/spray solution
Active substance:
  • Chlorhexidine gluconate
Target species:
  • Cattle
Route of administration:
  • Teat use

Product details

Active substance and strength:
  • Chlorhexidine gluconate
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Teat dip/spray solution
Withdrawal period by route of administration:
  • Teat use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD08AC02
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • Kenocidin Spray and Dip Chloorhexidine Digluconaat 5 mg/ml teat dip/teat spray sol. multidos. cont. 200 l
  • Kenocidin Spray and Dip Chloorhexidine Digluconaat 5 mg/ml teat dip/teat spray sol. multidos. cont. 60 l
  • Kenocidin Spray and Dip Chloorhexidine Digluconaat 5 mg/ml teat dip/teat spray sol. multidos. cont. 25 l
  • Kenocidin Spray and Dip Chloorhexidine Digluconaat 5 mg/ml teat dip/teat spray sol. multidos. cont. 20 l
  • Kenocidin Spray and Dip Chloorhexidine Digluconaat 5 mg/ml teat dip/teat spray sol. multidos. cont. 10 l
  • Kenocidin Spray and Dip Chloorhexidine Digluconaat 5 mg/ml teat dip/teat spray sol. multidos. cont. 5 l
  • Kenocidin Spray and Dip Chloorhexidine Digluconaat 5 mg/ml teat dip/teat spray sol. multidos. cont. 1 l

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 8(3) of Directive No 2001/83/EC)
Marketing authorisation holder:
  • Cid Lines
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cid Lines
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 108900
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0040/001
Concerned member states:
  • Bulgaria
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 19/01/2022
Download